
Subependymal Giant-Cell Astrocytoma: A Genetic Testing Perspective
Growing from the walls of the brain's ventricles, SEGA is often linked to tuberous sclerosis complex; TSC1 or TSC2 testing supports early detection and monitoring.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Growing from the walls of the brain's ventricles, SEGA is often linked to tuberous sclerosis complex; TSC1 or TSC2 testing supports early detection and monitoring.

Skin lesions, gastrointestinal symptoms and anaphylaxis can accompany the mast cell build-up in SMCD; STAT3 mutations affect degranulation and shape genetic testing.

Partial beta-hexosaminidase A activity lets GM2 ganglioside build up in nerve cells; carrier screening, prenatal testing and PGD are options for families at risk.

An extra thumb phalanx together with fused fingers and toes defines TPTPS. A ZRS variant reclassified as likely pathogenic, surgery and family planning are described.

Meningiomas grow from the membranes around the brain and spinal cord and often carry NF2 mutations. Targeted treatment, family risk and open VEGF questions are covered.

Moderate to severe hearing loss from birth with progressive vision loss marks type 2; deleting PDZD7 in cochlear hair cells caused hearing loss in mice.

Symptoms may hold off until adolescence or adulthood, bringing gradual hearing loss, night blindness and peripheral vision loss linked to CLRN1 mutations.

Methylmalonic acid builds up when vitamin B12 metabolism is disrupted; naming the mutation guides dietary changes and the dose and form of B12 supplementation.